Tenon medical, inc. announces pricing of $4.5 million public offering priced at-the-market under nasdaq rules

Los gatos, ca / accesswire / september 12, 2024 / tenon medical, inc. (nasdaq:tnon) ("tenon" or the "company"), a company transforming care for patients suffering with certain sacroiliac joint (si joint) disorders, today announced the pricing of its "reasonable best efforts" public offering with a single health-care focused institutional investor for the purchase and sale of up to 1,222,850 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 1,222,850 shares of common stock at a combined offering price of $3.68 per share and accompanying warrant, priced at-the-market under nasdaq rules (the "offering"). the company expects to receive aggregate gross proceeds of approximately $4.5 million, before deducting placement agent fees and other offering expenses, and assuming no exercise of the warrants.
NDAQ Ratings Summary
NDAQ Quant Ranking